An Adapted Evidence-Based Coaching Program for Fathers and Their Young Children in the Context of Home Visiting

by palligoelme@gmail.com | Jun 30, 2026 | Clinical Trials

​ Conditions: Positive Parenting Interventions: Behavioral: Filming Interactions to Nurture Development (FIND) Sponsors: University of Washington; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Stanford University...

HFNC for Postoperative Atelectasis After Laparoscopic Surgery

by palligoelme@gmail.com | Jun 30, 2026 | Clinical Trials

​ Conditions: Postoperative Atelectasis; Postoperative Pulmonary Complications Interventions: Other: High-Flow Nasal Cannula (HFNC); Other: Conventional Oxygen Therapy Sponsors: Bursa Yuksek Ihtisas Training and Research Hospital Not yet recruiting Conditions:...

Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma

by palligoelme@gmail.com | Jun 30, 2026 | Clinical Trials

​ Conditions: Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Cyclophosphamide; Drug: Fludarabine; Procedure: Leukapheresis; Procedure: Positron...

A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy

by palligoelme@gmail.com | Jun 29, 2026 | Clinical Trials

​ Conditions: Duchenne Muscular Dystrophy Interventions: Genetic: GNR-097; Genetic: Placebo followed by GNR-097 Sponsors: AO GENERIUM Recruiting Conditions: Duchenne Muscular Dystrophy Interventions: Genetic: GNR-097; Genetic: Placebo followed by GNR-097 Sponsors: AO...

Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City

by palligoelme@gmail.com | Jun 29, 2026 | Clinical Trials

​ Conditions: Opioid Use; Stimulant Use; Depression and Anxiety Symptoms Interventions: Behavioral: uMAT-R + enhanced community engagement; Behavioral: Original uMAT-R supplementary mHealth recovery intervention Sponsors: Washington University School of Medicine...

Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 in the Treatment of Chronic Hepatitis B

by palligoelme@gmail.com | Jun 29, 2026 | Clinical Trials

​ Conditions: HBV Infection Interventions: Drug: TVAX-028; Other: Adjuvant Sponsors: Grand Theravac Life Sciences (Nanjing) Co., Ltd. Not yet recruiting Conditions: HBV Infection Interventions: Drug: TVAX-028; Other: Adjuvant Sponsors: Grand Theravac Life Sciences...